Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: JDN who wrote (780)	8/17/1999 11:51:00 AM
From: DanZ	Read Replies (1) \| Respond to of 5582

JDN: Based on your last few posts, your motives are clear. You continue to misrepresent the facts and put a decidedly negative spin on almost everything that you post. The retailers where Zicam was sold in the second quarter have been clearly stated and all sales in Q2 were reorders from the limited retail base in place. None of the new retailers that recently placed orders bought Zicam in the second quarter. These include Walmart, Ride Aid, Target, to name a few. Sales of Zicam in the third quarter should be at least $3.5 million based on filling these stores alone. Your ridicule of Q2 sales of Zicam are without merit. Are you short GUMM by chance? If so, you were suckered by Wexler and have no idea what you are getting yourself into.

To: JDN who wrote (780)	8/17/1999 11:55:00 AM
From: out_of_the_loop	Read Replies (1) \| Respond to of 5582

As expected for the summer, low cold season and no advertising. You can verify all the distribution channels by talking to Jim Marini. His phone number is on the Zicam.com site. Orders are still coming in. If you are truly interested in a forward-looking approach, that is how you will verify your information. If you are interested in hyperbole, you can post nonfactual nonsense and sarcasm about "samples". Have a nice day. P..S. Welcome to the GUMM thread on the good side of town.